Details on the late-breaking abstract and posters are as follows: Topline Results from BOND-003: A Phase-3 Study of Intravesical Cretostimogene Grenadenorepvec for the Treatment of High-Risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback